Provided by Tiger Trade Technology Pte. Ltd.

VYNE Therapeutics Inc.

0.5916
+0.00360.61%
Volume:45.37K
Turnover:26.52K
Market Cap:19.69M
PE:-0.96
High:0.5968
Open:0.5800
Low:0.5800
Close:0.5880
52wk High:1.99
52wk Low:0.2805
Shares:33.29M
Float Shares:30.82M
Volume Ratio:0.53
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6192
EPS(LYR):-0.6192
ROE:-66.96%
ROA:-38.31%
PB:0.71
PE(LYR):-0.96

Loading ...

Dec 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Mar 13, 2024

Correspondence

Form CORRESP - Correspondence
Mar 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 20, 2023

Correspondence

Form CORRESP - Correspondence
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]